People

Inhaled drug company MannKind Corporation has announced the appointment of Kevin Kaiserman as VP, Medical Affairs and Safety. Kaiserman, a pedicatric endocrinologist, was most recently in private practice. The company markets Afrezza inhaled insulin, which was approved by the FDA in 2014, and is partnered with United Therapeutics on development of a treprostinil … [Read more...] about MannKind appoints Kevin Kaiserman as VP, Medical Affairs and Safety

Aerosol testing company Proveris Scientific has announced two new appointments: Joseph Werbeck rejoins the company as Senior Director of Technical Service and Mohamed Eldam joins Proveris as Applications Chemist. Werbeck, who will report to VP of Technical Service Alberto Correia, served as Director of Technical Service at Proveris from 2014-2018 before leaving for a … [Read more...] about Proveris Scientific announces two appointments

MannKind Corporation has announced the appointment of Alejandro Galindo as Chief Commercial Officer. Galindo most recently headed the Intensive Insulin Management business unit at Medtronic and previously served in a number of roles at GE Healthcare. In addition to marketing its Afrezza inhaled insulin, which was approved by the FDA in 2014, MannKind is partnered … [Read more...] about MannKind names Alejandro Galindo as Chief Commercial Officer

Nephron Pharmaceuticals said that it has hired Rita Boucher as Chief Quality Officer and is promoting Jamie Shuster to Chief Projects Officer and Stephanie Simmonds to Chief Clinical Officer. Boucher previously worked in quality assurance at Pfizer, as Cold Chain Project Manager at Genzyme, and in a number of different roles at AstraZeneca. Shuster has been Nephron's … [Read more...] about Nephron Pharmaceuticals announces new Chief Quality Officer, several promotions

Inhaled drug developer Senzer has announced major changes to its management "aimed at bolstering its commercialization strategy for COVID-19 and cannabinoid treatments." In May 2020, Senzer announced that it was developing two inhaled anti-virals delivered via MDI for the treatment of COVID-19 in addition to the cannabinoids it is developing based on its Systemic … [Read more...] about Senzer announces management changes, including new Chairman and CEO

Inhalation Sciences (ISAB) has named TFS Trial Form Support International Founder Daniel Spasic as Chairman of the Board. Spasic serves on the boards of several other companies, including connected spirometer maker NuvoAir. In May 2019, Inhalation Sciences announced that it intended to validate its PreciseInhale dosing system, which produces aerosols at a specified … [Read more...] about Inhalation Sciences appoints Daniel Spasic as Chairman of the Board

Inhaled drug CDMO Vectura has announced the appointments of Trevor Archbold, Robert Gurley, and Chris Vernall as Business Development Directors, reporting to recently appointed Chief Commercial Officer Mark Bridgewater. Archbold and Vernall will cover Europe; Gurley will be responsible for the US West Coast. Archbold was most recently Strategic Account Manager, … [Read more...] about Vectura appoints three new Business Development Directors

Liquidia Technologies has announced the appointment of former Teva Pharmaceuticals Global Head of Specialty Clinical Development Tushar Shah as the company's first Chief Medical Officer. Prior to his most recent position, Shah had served as Senior VP, Global Respiratory Research and Development at Teva. His career in pharmaceutical research has also included positions … [Read more...] about Tushar Shah joins Liquidia Technologies as Chief Medical Officer

Impel NeuroPharma has announced the resignation of Jon Congleton as President and CEO; Adrian Adams, who was appointed as Impel's Chairman of the Board of Directors in January 2020, will now add the CEO role. Adams has previously served as CEO of a number of pharmaceutical companies, including Aralez, Auxilium, Neurologix, Inspire Pharmaceuticals, Sepracor, and Kos. … [Read more...] about Impel NeuroPharma Chairman Adrian Adams takes over CEO role as Jon Congleton steps down